Description
ReliSlim is a prescription-based weight loss medication, classified as a Schedule 6 drug in South Africa and Schedule 4 in Namibia. It is formulated to assist individuals in their weight management journey, helping with appetite suppression and fat burning under medical supervision. ReliSlim is available in packet sizes of 30 or 90 tablets, making it a convenient option for extended use.
Ingredients:
- Each tablet contains 20 mg of d-Norpseudoephedrine hydrochloride, a potent appetite suppressant.
Side Effects: ReliSlim is generally well-tolerated when taken at the prescribed dosage. Common side effects, such as dry mouth and dry mucous membranes, can be managed by increasing water intake, which also aids in weight loss. To avoid insomnia, ensure the last dose is taken early in the day.
